Sheldon Litwin to Combined Modality Therapy
This is a "connection" page, showing publications Sheldon Litwin has written about Combined Modality Therapy.
Connection Strength
0.039
-
Risk factors for immediate prosthetic postmastectomy reconstruction. Am Surg. 1991 Aug; 57(8):514-21; discussion 522.
Score: 0.020
-
Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation. Cancer J Sci Am. 1996 Mar-Apr; 2(2):99-105.
Score: 0.007
-
Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study. Cancer. 1993 Oct 01; 72(7):2124-33.
Score: 0.006
-
Report of phase II trial of concurrent chemoradiotherapy with radical thoracic irradiation (60 Gy), infusional fluorouracil, bolus cisplatin and etoposide for clinical stage IIIB and bulky IIIA non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1993 Jun 15; 26(3):469-78.
Score: 0.006